EU clears drug made from milk of biotech goats

09/16/2006 | Times (London) (subscription required), The

European regulators have approved the anti-clotting drug ATryn for use in humans as the first medicine derived from biotech animal milk. GTC Biotherapeutics of the U.S. developed the drug for marketing by mid-2007, based on placing human genes into the DNA of goat milk, for treating people with the rare hereditary antithrombin deficiency.

View Full Article in:

Times (London) (subscription required), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC